Last reviewed · How we verify

NCT06117670

Gamma-irradiated Amniotic Membrane Graft in Posterior Colporrhaphy

Completed Phase 3 Last updated 2 December 2025
What this trial tests

Phase 3 trial testing posterior colporrhaphy using gamma-irradiated amniotic membrane as a graft in Rectocele; Female in 25 participants. Completed in 5 August 2025.

Timeline
1 November 2023
Primary endpoint
5 January 2025
5 August 2025

Quick facts

Lead sponsorAin Shams Maternity Hospital
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment25
Start date1 November 2023
Primary completion5 January 2025
Estimated completion5 August 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams Maternity Hospital

Who can join

Adults 30 to 60, female only, with Rectocele; Female or Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to test the benefit of using gamma-irradiated amniotic membrane as a graft in surgical repair for women with posterior vaginal wall defects. The main question it aims to answer is: • Is posterior colporrhaphy using gamma-irradiated amniotic membrane as a graft effective? Participants will undergo posterior colporrhaphy, which will be modified by adding gamma-irradiated amniotic membrane as a graft during the repair.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Rectocele; Female

Currently open trials in the same condition.

Other Ain Shams Maternity Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06117670.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing